CJ has been granted a patent for a strain of microalgae called CJM01, which belongs to the Thraustochytrium genus. This microalgae has a high content of polyunsaturated fatty acids, including docosahexaenoic acid (DHA). The patent claims the specific microalgae strain deposited under accession number KCTC 13538BP. The biomass produced from this microalgae strain is useful as a feed composition. GlobalData’s report on CJ gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Data Insights CJ Corp - Company Profile

Buy the Report

Data Insights

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

According to GlobalData’s company profile on CJ, NSAID cancer drugs was a key innovation area identified from patents. CJ's grant share as of September 2023 was 40%. Grant share is based on the ratio of number of grants to total number of patents.

Patent granted for cjmo1 microalgae of thraustochytrium genus

Source: United States Patent and Trademark Office (USPTO). Credit: CJ Corp

A recently granted patent (Publication Number: US11773417B2) discloses a specific strain of microalgae called CJMO1, which belongs to the Thraustochytrium genus. This strain has been deposited under the accession number KCTC 13538BP.

The patent claims that CJMO1 microalgae contain a high amount of docosahexaenoic acid (DHA), ranging from 40% to 60% of the total weight of fatty acids. DHA is a valuable omega-3 fatty acid known for its health benefits.

Furthermore, the patent claims that CJMO1 microalgae have a high productivity of DHA, ranging from 0.5 to 0.7 grams per liter per hour. This indicates that the microalgae can efficiently produce DHA in significant quantities.

The patent also describes methods for producing biomass and bio-oil using CJMO1 microalgae. In the biomass production method, the microalgae are cultured under heterotrophic conditions, meaning they obtain their energy from organic carbon sources. The culturing process involves using a culture medium containing a carbon source (such as glucose, fructose, or glycerol) and a nitrogen source (either organic, like yeast extract or beef extract, or inorganic, like ammonium nitrate or urea). The biomass produced through this method can be used to recover DHA.

Similarly, the bio-oil production method involves culturing CJMO1 microalgae and recovering lipids containing DHA from the microalgae or its cultured, dried, or pulverized products. This bio-oil can be a valuable source of DHA for various applications.

In summary, this granted patent highlights the CJMO1 microalgae strain, which belongs to the Thraustochytrium genus and has a high content and productivity of DHA. The patent also discloses methods for producing biomass and bio-oil using this microalgae strain, providing potential avenues for commercial production of DHA-rich products.

To know more about GlobalData’s detailed insights on CJ, buy the report here.

Data Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.